Literature DB >> 16580821

Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes.

Huiquan Lou1, Kuljeet Kaur, Anita K Sharma, Pawan K Singal.   

Abstract

BACKGROUND: Adriamycin (ADR) induced heart failure is associated with an increase in oxidative stress and apoptosis. Changes due to ADR in mitogen-activated protein kinases (ERK1/2 and p38 MAPKs), pro- and anti-apoptotic proteins (Bax and Bcl-xl) and apoptosis were examined in isolated adult rat cardiomyocytes.
METHODS: Isolated adult rat cardiomyocytes were exposed to different concentrations of ADR (0.1, 1 and 10mumol/L) and analyzed at different post-treatment durations. Antioxidant, trolox (20mumol/L) was used to determine involvement of oxidative stress on these changes.
RESULTS: Total ERK1/2 and p38 did not show any significant change. However, phosphorylated ERK1/2 showed a rapid increase (497%) after 5min of ADR treatment, peaking (610%) at 10min followed by a decline to submaximal levels at 30min (280%) and 60min (247%). Phosphorylated p38 showed no changes until after 30min, peaking (284%) at 1h, followed by a small decline at 2h. These changes were found to be dose-dependent (0.1, 1 and 10mumol/L of ADR). Adriamycin induced apoptosis was confirmed by Hoechst staining. The ratio of Bax/Bcl-xl increased in a dose-dependent manner. At 10mumol/L, this ratio increased to a maximum at 1h, remained steady at the level for up to 12h, followed by a decline below the base line at 24h. Antioxidant, trolox modulated the ADR-induced increase in phosphorylation of ERK1/2 and p38 MAPKs as well as in the ratio of Bax/Bcl-xl.
CONCLUSION: It is suggested that ADR activates MAP kinases, followed by an activation of pro-apoptotic protein Bax which results in cardiomyocyte apoptosis and these effects appear to be mediated by ADR-induced oxidative stress.

Entities:  

Year:  2006        PMID: 16580821     DOI: 10.1016/j.pathophys.2006.02.004

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  9 in total

1.  Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.

Authors:  Ana Ludke; Anita K Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

2.  Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.

Authors:  Matthew Zeglinski; Ana Ludke; Davinder S Jassal; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2011

3.  In vivo hyperglycaemia exposure elicits distinct period-dependent effects on human pancreatic progenitor differentiation, conveyed by oxidative stress.

Authors:  Thomas A Legøy; Luiza Ghila; Heidrun Vethe; Shadab Abadpour; Andreas F Mathisen; Joao A Paulo; Hanne Scholz; Helge Raeder; Simona Chera
Journal:  Acta Physiol (Oxf)       Date:  2020-01-08       Impact factor: 6.311

4.  Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Authors:  T Simůnek; M Sterba; O Popelová; H Kaiserová; M Adamcová; M Hroch; P Hasková; P Ponka; V Gersl
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

5.  Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.

Authors:  Yunfang Zhang; Haitham El-Sikhry; Ketul R Chaudhary; Sri Nagarjun Batchu; Anooshirvan Shayeganpour; Taibeh Orujy Jukar; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Page Myers; Douglas C Rouse; Julie Foley; Abraham Nyska; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

6.  Myricitrin Protects against Doxorubicin-Induced Cardiotoxicity by Counteracting Oxidative Stress and Inhibiting Mitochondrial Apoptosis via ERK/P53 Pathway.

Authors:  Jing Sun; Guibo Sun; Xiaolan Cui; Xiangbao Meng; Meng Qin; Xiaobo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-14       Impact factor: 2.629

7.  Renoprotective Effect of Plantago major Against Proteinuria and Apoptosis Induced by Adriamycin in Rat.

Authors:  Zohreh Naji Ebrahimi Yazd; Zahra Samadi Noshahr; Sara Hosseinian; Mohammad Naser Shafei; Alireza Ebrahimzadeh Bideskan; Reza Mohebbati; Nazanin Entezari Heravi; Samira Shahraki; Somayeh Mahzari; Abolfazl Khajavi Rad
Journal:  J Pharmacopuncture       Date:  2019-03-31

8.  Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).

Authors:  Tianqi Chen; Peiying Yang; Yingjie Jia
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

9.  Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.

Authors:  Ana Ludke; Gauri Akolkar; Prathapan Ayyappan; Anita K Sharma; Pawan K Singal
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.